Iterum Therapeutics Plc (ITRMF)
0.0499
+0.02
(+66.33%)
USD |
OTCM |
Apr 01, 16:00
Iterum Therapeutics EPS Diluted (Quarterly) : -0.196 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.0587 |
| Jazz Pharmaceuticals Plc | 3.207 |
| Prothena Corp. Plc | -0.401 |
| GH Research Plc | -0.2279 |
| Cosmo Pharmaceuticals NV | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.979M |
| Revenue (Quarterly) | 0.39M |
| Total Expenses (Quarterly) | 9.369M |
| Enterprise Value | 24.96M |
| Gross Profit Margin (Quarterly) | 3.85% |
| Profit Margin (Quarterly) | -2.30K% |
| Earnings Yield | -1.50K% |
| Normalized Earnings Yield | -1330.46 |